Literature DB >> 26291802

Endogenous thrombin potential in polycystic ovary syndrome: the association to body mass index, insulin resistance, and inflammation.

Mubeena Aziz1, Johannes J Sidelmann2, Marie Louise Muff Wissing3, Jens Faber4, Sven O Skouby1.   

Abstract

OBJECTIVES: The objective of this study is to investigate plasma endogenous thrombin generation in four different phenotypes of polycystic ovary syndrome (PCOS) defined by Body Mass Index (BMI) and insulin resistance (IR). PCOS is diagnosed according to the Rotterdam criteria.
DESIGN: Multicenter cross-sectional study.
SETTING: Two major University Hospitals in the Capital region of Denmark. PATIENTS: Hundred forty-eight European women with PCOS were consecutively recruited during April 2010-February 2012. Clinical examination, blood sampling, and DEXA scan were performed. MAIN OUTCOME MEASURES: Endogenous thrombin potential (ETP).
RESULTS: PCOS women with phenotype BMI > 25 + IR have increased potential of thrombin generation. ETP is associated with total body fat mass, IR, and CRP.
CONCLUSIONS: Obese and insulin resistant women with PCOS have elevated level of ETP corresponding to increased risk of CVD. ETP is related to well-known CVD risk factors in PCOS but not in general to the Rotterdam criteria.

Entities:  

Keywords:  Endogenous thrombin generation; PCOS; inflammation; insulin resistance; obesity

Mesh:

Substances:

Year:  2015        PMID: 26291802     DOI: 10.3109/09513590.2015.1032930

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  3 in total

1.  DIA proteomics analysis through serum profiles reveals the significant proteins as candidate biomarkers in women with PCOS.

Authors:  Ying Yu; Panli Tan; Zhenchao Zhuang; Zhejiong Wang; Linchao Zhu; Ruyi Qiu; Huaxi Xu
Journal:  BMC Med Genomics       Date:  2021-05-09       Impact factor: 3.063

2.  Clomiphene Citrate Treatment Cycle Outcomes of Polycystic Ovary Syndrome Patients Based on Basal High Sensitive C-Reactive Protein Levels: A Cross-Sectional Study.

Authors:  Serkan Kahyaoglu; Omer Hamid Yumuşak; Sebnem Ozyer; Meryem Kuru Pekcan; Merve Erel; Mahmut Nedim Cicek; Salim Erkaya; Yasemin Tasci
Journal:  Int J Fertil Steril       Date:  2016-11-01

3.  Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential.

Authors:  Malin Nylander; Signe Frøssing; Caroline Kistorp; Jens Faber; Sven O Skouby
Journal:  Endocr Connect       Date:  2017-01-24       Impact factor: 3.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.